The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
Authors
Keywords
-
Journal
BMC Medicine
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-08-09
DOI
10.1186/1741-7015-10-87
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic relevance of circulating biomarkers in patients with lung cancer
- (2017) Rafael Molina et al. Cancer Biomarkers
- Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
- (2012) J. R. Prensner et al. Science Translational Medicine
- Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel
- (2011) Eva J Kantelhardt et al. BMC CANCER
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
- (2011) D. W. Cramer et al. Cancer Prevention Research
- Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology
- (2011) Guido Fadda et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer
- (2011) Claus Høgdall et al. GYNECOLOGIC ONCOLOGY
- Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions
- (2011) Alexandre de la Taille et al. JOURNAL OF UROLOGY
- Cancer: Missing the mark
- (2011) Lizzie Buchen NATURE
- Cancer trial errors revealed
- (2011) Eugenie Samuel Reich NATURE
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
- (2011) Rafael Molina et al. TUMOR BIOLOGY
- Why have protein biomarkers not reached the clinic?
- (2011) Samir M Hanash Genome Medicine
- Cancer Biomarkers: Can We Turn Recent Failures into Success?
- (2010) E. P. Diamandis JNCI-Journal of the National Cancer Institute
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers
- (2008) E. P. Diamandis et al. CLINICAL CHEMISTRY
- Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
- (2008) G. Sardana et al. CLINICAL CHEMISTRY
- HBME‐1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma
- (2008) Min‐En Nga et al. DIAGNOSTIC CYTOPATHOLOGY
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
- (2008) Margaret S. Pepe et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation